Dividing out quantification uncertainty enables assessment of differential transcript usage with limma and edgeR
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf1305 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Pedro L Baldoni und 4 weiteren Autor:innen. Beteiligte Einrichtung: Bioinformatics and Computational Biology Division, WEHI, Parkville VIC 3052, Australia. Hauptthemen laut MEDLINE: Software, Gene Expression Profiling, Computational Biology. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chan Zuckerberg Initiative, National Health and Medical Research Council, University of Melbourne.
Abstract (Originalsprache)
Differential transcript usage (DTU) refers to changes in the relative abundance of transcript isoforms of the same gene between experimental conditions, even when the total expression of the gene does not change. DTU analysis requires the quantification of individual isoforms from RNA-seq data, which has a high level of uncertainty due to transcript overlap and read-to-transcript ambiguity (RTA). Popular DTU analysis methods do not directly account for the RTA overdispersion within their statistical frameworks, leading to reduced statistical power or poor error rate control, particularly in scenarios with small sample sizes. This article presents limma and edgeR analysis pipelines that account for RTA during DTU assessment. Leveraging recent advancements in the limma and edgeR Bioconductor packages, we propose DTU analysis pipelines optimized for small and large datasets with a unified interface via the diffSplice function. The pipelines make use of divided counts to remove RTA-induced dispersion from transcript isoform counts and account for the sparsity in transcript-level counts. Simulations and analyses of real data from mouse mammary epithelial cells demonstrate that the diffSplice pipelines provide greater power, improved efficiency, and improved false discovery rate control compared to existing specialized DTU methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Bioinformatics and Computational Biology Division, WEHI, Parkville VIC 3052, Australia.
- Department of Medical Biology, The University of Melbourne, Parkville VIC 3010, Australia.
- ACRF Cancer Biology and Stem Cells Division, WEHI, Parkville VIC 3052, Australia.
ORCID-Profile: Pedro L Baldoni, Lizhong Chen, Mengbo Li, Yunshun Chen, Gordon K Smyth
Förderung
- Chan Zuckerberg Initiative
- National Health and Medical Research Council
- University of Melbourne
- State Government of Victoria
Zitieren
APA
Baldoni, P. L., Chen, L., Li, M., Chen, Y., & Smyth, G. K. (2025). Dividing out quantification uncertainty enables assessment of differential transcript usage with limma and edgeR. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf1305
Vancouver
Baldoni PL, Chen L, Li M, Chen Y, Smyth GK. Dividing out quantification uncertainty enables assessment of differential transcript usage with limma and edgeR. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf1305
BibTeX
@article{Baldoni2025,
author = {Baldoni, Pedro L and Chen, Lizhong and Li, Mengbo and Chen, Yunshun and Smyth, Gordon K},
title = {Dividing out quantification uncertainty enables assessment of differential transcript usage with limma and edgeR},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf1305}
}
EUVIMED